The Journal of rheumatology. Supplement最新文献

筛选
英文 中文
Axial Spondyloarthritis in Diffuse Idiopathic Skeletal Hyperostosis 弥漫性特发性骨骼增生引起的轴性脊椎关节炎
The Journal of rheumatology. Supplement Pub Date : 2022-03-15 DOI: 10.3899/jrheum.220082
K. Aso, M. Kato, T. Atsumi
{"title":"Axial Spondyloarthritis in Diffuse Idiopathic Skeletal Hyperostosis","authors":"K. Aso, M. Kato, T. Atsumi","doi":"10.3899/jrheum.220082","DOIUrl":"https://doi.org/10.3899/jrheum.220082","url":null,"abstract":"Axial spondyloarthritis (axSpA) and diffuse idiopathic skeletal hyperostosis (DISH) involve tendon and ligament ossification showing similarity on spinal radiographs. Differentiating axSpA from DISH facilitates proper treatment and improves inflammatory pain; however, the overlap between axSpA and DISH delays its diagnosis.","PeriodicalId":35278,"journal":{"name":"The Journal of rheumatology. Supplement","volume":"41 1","pages":"956 - 957"},"PeriodicalIF":0.0,"publicationDate":"2022-03-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"74685327","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Fibroblast Growth Factor 23 Levels in Pulmonary Involvement Associated With Systemic Sclerosis: A Proof-of-concept Study 成纤维细胞生长因子23水平与系统性硬化症相关的肺受累:一项概念验证研究
The Journal of rheumatology. Supplement Pub Date : 2022-03-15 DOI: 10.3899/jrheum.211156
L. Amezcua-Guerra, M. Mora-Ramírez, G. Vancini, V. Jiménez-Rojas, R. Márquez-Velasco
{"title":"Fibroblast Growth Factor 23 Levels in Pulmonary Involvement Associated With Systemic Sclerosis: A Proof-of-concept Study","authors":"L. Amezcua-Guerra, M. Mora-Ramírez, G. Vancini, V. Jiménez-Rojas, R. Márquez-Velasco","doi":"10.3899/jrheum.211156","DOIUrl":"https://doi.org/10.3899/jrheum.211156","url":null,"abstract":"Systemic sclerosis (SSc) is a devastating disease associated with lung involvement, primarily interstitial lung disease (ILD) and pulmonary hypertension (PH).1 Although computed tomography (CT) and right heart catheterization accurately identify cardiopulmonary injury,2 their high cost and technical complexity make them inaccessible to most nonspecialized health centers. Thus, the timely detection of lung involvement remains a challenge in real-world settings.","PeriodicalId":35278,"journal":{"name":"The Journal of rheumatology. Supplement","volume":"2 1","pages":"542 - 544"},"PeriodicalIF":0.0,"publicationDate":"2022-03-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"76079623","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Promoting Diversity, Equity, and Inclusion for Psoriatic Diseases. 促进银屑病的多样性、公平性和包容性。
The Journal of rheumatology. Supplement Pub Date : 2022-03-15 DOI: 10.3899/jrheum.211330
J. Takeshita, J. Chau, K. Callis Duffin, N. Goel
{"title":"Promoting Diversity, Equity, and Inclusion for Psoriatic Diseases.","authors":"J. Takeshita, J. Chau, K. Callis Duffin, N. Goel","doi":"10.3899/jrheum.211330","DOIUrl":"https://doi.org/10.3899/jrheum.211330","url":null,"abstract":"There is increasing evidence of racial and ethnic disparities in the evaluation and treatment of people with psoriasis (PsO) and psoriatic arthritis, and inadequate racial/ethnic diversity in psoriatic disease (PsD) research. At the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA) 2021 annual meeting, a program focusing on diversity, equity, and inclusion (DEI) was presented to highlight known health and healthcare disparities in PsD. There is limited understanding of the prevalence and severity of PsD and how it affects quality of life among racial/ethnic minorities with PsD. Educational gaps and lack of diversity in our dermatology workforce may be contributing to challenges in appropriately diagnosing and treating PsO in darker skin types. Racial/ethnic minorities are also inadequately represented in clinical research, including trial recruitment and participation, for PsD. A panel of patient research partners, researchers, and clinicians ended the session with a broad discussion on how GRAPPA can better ensure racial/ethnic DEI in their educational, research, and clinical missions.","PeriodicalId":35278,"journal":{"name":"The Journal of rheumatology. Supplement","volume":"25 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-03-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"77344174","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 3
Tumor Necrosis Factor-α Inhibition Before and After Rituximab Treatment in Juvenile Idiopathic Arthritis: What Shall We Expect? A Pilot Study 利妥昔单抗治疗青少年特发性关节炎前后肿瘤坏死因子-α抑制:我们应该期待什么?一项初步研究
The Journal of rheumatology. Supplement Pub Date : 2022-03-15 DOI: 10.3899/jrheum.211039
A. Marino, F. Orsini, F. Pregnolato, R. Cimaz
{"title":"Tumor Necrosis Factor-α Inhibition Before and After Rituximab Treatment in Juvenile Idiopathic Arthritis: What Shall We Expect? A Pilot Study","authors":"A. Marino, F. Orsini, F. Pregnolato, R. Cimaz","doi":"10.3899/jrheum.211039","DOIUrl":"https://doi.org/10.3899/jrheum.211039","url":null,"abstract":"Rituximab (RTX), a chimeric monoclonal antibody against B cell antigen CD20, has been used in patients with recalcitrant juvenile idiopathic arthritis ( JIA) with some efficacy.1,2 The resetting of peripheral B cells promoted by RTX represents quite an interesting option in autoimmune diseases such as JIA, not only for the immediate effect but also for the possible use of other therapies that might be necessary to achieve disease control.","PeriodicalId":35278,"journal":{"name":"The Journal of rheumatology. Supplement","volume":"33 1","pages":"654 - 656"},"PeriodicalIF":0.0,"publicationDate":"2022-03-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"86991998","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Alterations of Plasma Microbiome: A Potentially New Perspective to the Dysbiosis in Systemic Lupus Erythematosus? 血浆微生物群的改变:系统性红斑狼疮生态失调的潜在新视角?
The Journal of rheumatology. Supplement Pub Date : 2022-03-15 DOI: 10.3899/jrheum.220023
Yudong Liu, Fei Xiao, Rui Zhang, Xuan Zhang
{"title":"Alterations of Plasma Microbiome: A Potentially New Perspective to the Dysbiosis in Systemic Lupus Erythematosus?","authors":"Yudong Liu, Fei Xiao, Rui Zhang, Xuan Zhang","doi":"10.3899/jrheum.220023","DOIUrl":"https://doi.org/10.3899/jrheum.220023","url":null,"abstract":"The human microbiome, which consists of the microbial communities inhabiting the human body, has sparked growing excitement in both basic research and clinical practice.1,2 Gut microbiota, in particular, has been considered a major environmental factor in modulating immune responses in autoimmune diseases (ADs).3,4.","PeriodicalId":35278,"journal":{"name":"The Journal of rheumatology. Supplement","volume":"12 1","pages":"549 - 551"},"PeriodicalIF":0.0,"publicationDate":"2022-03-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"82122290","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Janus Kinase Inhibitors: Safety in Patients With Psoriatic Arthritis. Janus激酶抑制剂:银屑病关节炎患者的安全性。
The Journal of rheumatology. Supplement Pub Date : 2022-03-15 DOI: 10.3899/jrheum.211329
P. Nash
{"title":"Janus Kinase Inhibitors: Safety in Patients With Psoriatic Arthritis.","authors":"P. Nash","doi":"10.3899/jrheum.211329","DOIUrl":"https://doi.org/10.3899/jrheum.211329","url":null,"abstract":"Janus kinase inhibitors ( JAKi; or Jakinibs) have become widely prescribed around the world for a variety of immune-mediated inflammatory diseases, including psoriatic arthritis. A previous noninferiority surveillance study of patients aged > 50 years with rheumatoid arthritis and ≥ 1 additional cardiac risk factor raised a number of safety concerns. This review focuses on available safety data from peer-reviewed publications, as well as the most recent presentations from major conferences highlighting JAKi-associated adverse effects. The safety data for several types of JAKi are reviewed. The latest available safety data for tofacitinib, upadacitinib, filgotinib, deucravacitinib, and brepocitinib is presented. In addition, the findings from the oral surveillance study will be discussed to put safety concerns into context.","PeriodicalId":35278,"journal":{"name":"The Journal of rheumatology. Supplement","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-03-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"86244660","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Toward a Sonographic Composite Index for Diagnosis in Psoriatic Arthritis: Highlights From the GRAPPA Ultrasound Workshop. 用于诊断银屑病关节炎的超声综合指数:来自GRAPPA超声研讨会的亮点。
The Journal of rheumatology. Supplement Pub Date : 2022-03-15 DOI: 10.3899/jrheum.211339
S. Aydın, L. Eder, G. Kaeley
{"title":"Toward a Sonographic Composite Index for Diagnosis in Psoriatic Arthritis: Highlights From the GRAPPA Ultrasound Workshop.","authors":"S. Aydın, L. Eder, G. Kaeley","doi":"10.3899/jrheum.211339","DOIUrl":"https://doi.org/10.3899/jrheum.211339","url":null,"abstract":"The ability to visualize musculoskeletal structures with high-resolution ultrasound is an asset to understanding the complexity of psoriatic arthritis (PsA). During the 2021 Annual Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA) meeting, 3 topics were presented and discussed in the ultrasound workshop: (1) the progress on the Diagnostic Ultrasound Enthesitis Tool (DUET) project; (2) the sonographic evaluation of joints in PsA-GRAPPA joint project; and (3) extrasynovial lesions in PsA. The ultrasound group aims to develop sonographic tools that are feasible and can be used in standard care to diagnose PsA early. The discussions around these topics will shape the group's work toward developing a composite index to diagnose PsA early.","PeriodicalId":35278,"journal":{"name":"The Journal of rheumatology. Supplement","volume":"9 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-03-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"84513281","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
What Constitutes a Positive MRI for Clinical Trial Recruitment of Psoriatic Arthritis Patients With Axial Involvement? 什么构成了银屑病关节炎患者轴向受累的临床试验招募的阳性MRI ?
The Journal of rheumatology. Supplement Pub Date : 2022-03-15 DOI: 10.3899/jrheum.211340
W. Maksymowych, M. Østergaard
{"title":"What Constitutes a Positive MRI for Clinical Trial Recruitment of Psoriatic Arthritis Patients With Axial Involvement?","authors":"W. Maksymowych, M. Østergaard","doi":"10.3899/jrheum.211340","DOIUrl":"https://doi.org/10.3899/jrheum.211340","url":null,"abstract":"There has been a resurgence of interest in defining the axial inflammation component of psoriatic arthritis (PsA) since recent randomized controlled trials (RCTs) raised the possibility that this entity may respond differentially to therapeutics compared to patients with axial spondyloarthritis. A workshop was conducted during the 2021 Group for Research and Assessment of Psoriasis and Psoriatic Arthritis annual meeting to review the literature on diagnosing PsA and to determine which criteria might be most appropriate. There was quite strong agreement that magnetic resonance imaging (MRI) had an important role to play in helping to define axial inflammation in PsA and that a data-driven methodology for generating optimal MRI quantitative cut-offs for lesions in the sacroiliac joints and/or spine that reflect imaging typical of axial inflammation in PsA would be most desirable.","PeriodicalId":35278,"journal":{"name":"The Journal of rheumatology. Supplement","volume":"3 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-03-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"74872272","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Young-GRAPPA at the Annual GRAPPA Meeting: Presentation of a New Group Within GRAPPA and Its Vision. Young-GRAPPA在GRAPPA年度会议上:介绍GRAPPA内部的一个新小组及其愿景。
The Journal of rheumatology. Supplement Pub Date : 2022-03-01 DOI: 10.3899/jrheum.211327
L. V. van Mens, G. Ayan, L. Coates, Roxana Coras, Dimitri L F Silva, Sebastián Herrera, A. Ishchenko, H. Jethwa, H. Johnsson, David Simon, A. Vivekanantham, F. Proft
{"title":"Young-GRAPPA at the Annual GRAPPA Meeting: Presentation of a New Group Within GRAPPA and Its Vision.","authors":"L. V. van Mens, G. Ayan, L. Coates, Roxana Coras, Dimitri L F Silva, Sebastián Herrera, A. Ishchenko, H. Jethwa, H. Johnsson, David Simon, A. Vivekanantham, F. Proft","doi":"10.3899/jrheum.211327","DOIUrl":"https://doi.org/10.3899/jrheum.211327","url":null,"abstract":"At the 2021 Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA) annual meeting, a separate group was created (Young-GRAPPA) to address the challenges of young researchers and physicians beginning their careers. This paper presents the initial organizational framework and different components and aims of this group. We were able to enroll over 50 young researchers as a result of this meeting.","PeriodicalId":35278,"journal":{"name":"The Journal of rheumatology. Supplement","volume":"52 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"85147696","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Why Should It Be Different From the Other Side? A Parent and Pediatrician’s Perspective of a Child With Kawasaki Disease 为什么它与另一边不同?父母和儿科医生对川崎病患儿的看法
The Journal of rheumatology. Supplement Pub Date : 2022-03-01 DOI: 10.3899/jrheum.211159
K. Gunasuntharam
{"title":"Why Should It Be Different From the Other Side? A Parent and Pediatrician’s Perspective of a Child With Kawasaki Disease","authors":"K. Gunasuntharam","doi":"10.3899/jrheum.211159","DOIUrl":"https://doi.org/10.3899/jrheum.211159","url":null,"abstract":"","PeriodicalId":35278,"journal":{"name":"The Journal of rheumatology. Supplement","volume":"83 1","pages":"333 - 333"},"PeriodicalIF":0.0,"publicationDate":"2022-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"88758673","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信